FHB
OCUL icon

First Hawaiian Bank’s Ocular Therapeutix OCUL Stock Holding History

First Hawaiian Bank’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-11,500
Closed -$79K – 1861
2018
Q3 		$79K Buy
+11,500
New +$72.2K ﹤0.01% 1014

Other funds holding OCUL

SR
Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

First Hawaiian Bank's OCUL Position: Q4 2018 in Review

First Hawaiian Bank sold out of Ocular Therapeutix (OCUL) in Q4 2018, closing a stake of 11,500 shares — an estimated $79K sold.

First Hawaiian Bank first reported a position in OCUL in Q3 2018 and held it in 1 quarter. The position peaked at $79K in Q3 2018. 69 funds tracked by Wall St. Rank hold OCUL as of Q4 2018.

  • First Hawaiian Bank reported no remaining Ocular Therapeutix position as of Q4 2018 after selling out during the quarter.
  • First Hawaiian Bank sold 11,500 Ocular Therapeutix shares in Q4 2018, an estimated $79K.
  • First Hawaiian Bank first reported a position in Ocular Therapeutix in Q3 2018 and held it in 1 quarter.
  • First Hawaiian Bank's Ocular Therapeutix position peaked at $79K in Q3 2018.
  • 69 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q4 2018.

Based on First Hawaiian Bank's 13F filing for Q4 2018, filed 11 Jan 2019.